In addition, kukoamine A improved gross motor function and neuronal activity in a Parkinson's disease model, increased the number of tyrosine hydroxylase (TH)-positive cells in the substantia nigra (SN) and striatum (Str), and decreased the expression of alpha-synuclein in the brain. The gene discussed is SNCA; the disease is Parkinson disease.